These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease. Ma C, Downes M, Jain R, Ientilucci M, Fleshner N, Perlis N, van der Kwast T. Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188 [Abstract] [Full Text] [Related]
4. Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients. Hansum T, Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Osanto S, Pelger RCM, van Wezel T, van der Poel H, Bekers E, Helleman J, Remmers S, van Leenders GJLH. Mod Pathol; 2021 Nov; 34(11):2064-2070. PubMed ID: 34175896 [Abstract] [Full Text] [Related]
5. Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis. Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Helleman J, Roobol MJ, van Leenders GJLH. Mod Pathol; 2019 Jan; 32(1):139-146. PubMed ID: 30349027 [Abstract] [Full Text] [Related]
6. Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. Kweldam CF, Wildhagen MF, Steyerberg EW, Bangma CH, van der Kwast TH, van Leenders GJ. Mod Pathol; 2015 Mar; 28(3):457-64. PubMed ID: 25189638 [Abstract] [Full Text] [Related]
16. Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy. Downes MR, Xu B, van der Kwast TH. Eur J Cancer; 2021 May; 148():432-439. PubMed ID: 33077335 [Abstract] [Full Text] [Related]
17. Prostate Carcinoma Grade and Length But Not Cribriform Architecture at Positive Surgical Margins Are Predictive for Biochemical Recurrence After Radical Prostatectomy. Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Helleman J, Roobol MJ, van Leenders GJLH. Am J Surg Pathol; 2020 Feb; 44(2):191-197. PubMed ID: 31592799 [Abstract] [Full Text] [Related]
20. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy. Klein EA, Yousefi K, Haddad Z, Choeurng V, Buerki C, Stephenson AJ, Li J, Kattan MW, Magi-Galluzzi C, Davicioni E. Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945 [Abstract] [Full Text] [Related] Page: [Next] [New Search]